Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressin Following the Fontan Operation
NCT02975999Phase 3Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Dec 2016
- Primary completion
- Dec 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pleural effusion comparing Vasopressin with Placebo (2 arms). Primary endpoint: Chest Tube Drainage at 1 month. Started Dec 2016; status: completed.
02
Drugs
vasopressin
03
Conditions
pleural effusion
Beyond the preview
Go deeper on NCT02975999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02975999.